Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns; BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses; and Dream Sight, an audio and video monitor that enables parents to monitor their child. In addition, the company offers Dream Duo, which integrates Dream Sock and Dream Sight to create a connected health and safety system; Owlet360, a subscription service that provides personalized understanding of the babies' development, health, and sleep trends; and accessories, such as fabric accessory socks and the Owlet Sock Travel Case. The company was founded in 2012 and is headquartered in Lehi, Utah.…
Owlet (OWLT) Stock Fair Value Moves Lower After Camera Safety Update
Owlet (NYSE: OWLT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 108 employees.
The shares were at 2.930 USD on 20 November 2026, down 74.2% over 52 weeks. Its 52-week range is 2.750 USD to 16.94 USD: the price is 82.7% below the high and 6.5% above the low.
Its market capitalisation is 87.58M USD.
Owlet reports return on equity of -111.9%, an operating margin of -7.3% and revenue down 5.0% year over year.
It holds more cash than debt, a net cash position of 20.60M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 9.000 USD is 207.2% above the current price. The next earnings report is expected on 4 March 2027.